English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

P. Hasbak, O. Saetrum Opgaard, K. Eskesen, S. Schifter, H. Arendrup, J. Longmore, and L. Edvinsson Department of Clinical Experimental Research, University Hospital of Copenhagen, Glostrup, Denmark; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Glostrup, Denmark; Department of Pharmacology, College of Medicine, University of California at Irvine, Irvine, CA; Department of Thoracic Surgery, Rigshospitalet, Copenhagen, Denmark; Merck Sharp & Dohme, Neuroscience Research Centre, Harlow, Essex, U.K.

the scientific world journal/thescientificworldjournal

A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries